{{Rsnum
|rsid=15561
|Gene=NAT1
|Chromosome=8
|position=18223142
|Orientation=plus
|GMAF=0.4288
|Gene_s=NAT1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 9.1 | 31.8 | 59.1
| HCB | 27.4 | 48.1 | 24.4
| JPT | 30.4 | 49.1 | 20.5
| YRI | 24.6 | 57.0 | 18.3
| ASW | 23.2 | 57.1 | 19.6
| CHB | 27.4 | 48.1 | 24.4
| CHD | 23.9 | 54.1 | 22.0
| GIH | 17.3 | 44.9 | 37.8
| LWK | 32.7 | 43.6 | 23.6
| MEX | 33.3 | 42.1 | 24.6
| MKK | 15.6 | 47.4 | 37.0
| TSI | 9.8 | 44.1 | 46.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=23161286
|Title=Differential haplotype amplification leads to misgenotyping of heterozygote as homozygote when using single nucleotide mismatch primer
}}

{{PMID Auto
|PMID=14724163
|Title=Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases.
|OA=1
}}

{{PMID Auto
|PMID=16112301
|Title=NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
|OA=1
}}

{{PMID Auto
|PMID=16416399
|Title=Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes.
|OA=1
}}

{{PMID Auto
|PMID=16847422
|Title=Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.
|OA=1
}}

{{PMID Auto
|PMID=21290563
|Title=Functional effects of genetic polymorphisms in the N-acetyltransferase 1 coding and 3' untranslated regions.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}